Clinical Trial Update: Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler [Phase 1]

View source ↗

Summary

Phase 1 dose-proportionality study evaluating blood levels of Fluticasone Furoate and Vilanterol after different FF/VI inhaled doses in asthma; the study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)
• Fluticasone Furoate/Vilanterol (fluticasone furoate/vilanterol)
• Vilanterol (vilanterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED